— Know what they know.
Not Investment Advice

VLS.AX ASX

Vita Life Sciences Limited
1W: +0.0% 1M: -0.4% 3M: +12.7% YTD: +6.2% 1Y: +22.1% 3Y: +95.7% 5Y: +168.0%
A$2.77 ($1.93)
+0.01 (+0.36%)
 
Weekly Expected Move ±1.8%
A$3 A$3 A$3 A$3 A$3
ASX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 57 · A$150.1M mcap · 12M float · 0.104% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapA$150.1M ($104.3M)
52W Range1.73-2.84
Volume14,685
Avg Volume12,876
Beta0.48
DividendA$0.14
Analyst Ratings
No analyst coverage
Company Info
CEOAndrew OKeefe
Employees400
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2007-07-09
1-5 Chalmers Crescent
Mascot, NSW 2020
AU
61 2 9545 2633
About Vita Life Sciences Limited

Vita Life Sciences Limited is an Australian healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and nutritional supplements. The company's reach spans Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. In addition to core supplements, their product range encompasses minerals, various herbs, and superfoods. They offer solutions targeting a broad spectrum of therapeutic areas, including nervous system support, general nutrition, immunity, hair, skin, and nails, liver and digestion, weight management, cardiovascular health, pain and inflammation, pregnancy and breastfeeding, and health specifically for men, women, and children. Products also provide antioxidant benefits and support for bones and joints. Marketed under their prominent brands—Herbs of Gold, VitaHealth, and VitaScience—these offerings are sold through pharmacies and health food channels. Established in 1947, Vita Life Sciences Limited is headquartered in Kirrawee, Australia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms